The Arthritis Foundation funds a study that aims to slow or stop osteoarthritis.
Morgan Jones, MD, MPH, of Mass General Brigham of Harvard Medical School, is leading a three-center, randomized, placebo-controlled trial to test a corticosteroid in people at risk of developing osteoarthritis due to an injury, known as post-traumatic osteoarthritis (OA). The scientific team will determine if an injection of long-acting triamcinolone at the time of knee surgery to remove meniscus cartilage (arthroscopic partial meniscectomy) can slow or stop the biochemistry of cartilage degradation that causes OA. The project is titled “The Corticosteroid Meniscectomy Trial,” or CoMeT.
“Arthroscopic meniscectomy is one of the most common surgical procedures in the world. In knee osteoarthritis, meniscus plays a key role and should be studied in clinical trials,” says Jason Kim, PhD, the Vice President of Osteoarthritis Research Programs at the Arthritis Foundation. Dr. Jones and his family at the Louisa May Alcott Museum
in Concord, Massachusetts.
Photo courtesy of Dr. Morgan H. Jones.
The Arthritis Foundation has invested over $2.2M into the ongoing CoMeT Study — one of the first projects of the Osteoarthritis Clinical Trial Network (OA-CTN) and an inspiration for the larger PIKASO Project. CoMeT is a predecessor of the PIKASO Project and established many of the ideas, concepts and techniques to be used in upcoming clinical trials supported by the Arthritis Foundation.
“Our activity in clinical trials is a keystone to achieving the Arthritis Foundation's goals and overall mission to serve patients,” says Maria Vassileva, PhD, the Senior Vice President of Science Strategy at the Arthritis Foundation.
Get involved with the arthritis community. Tell us a little about yourself and, based on your interests, you’ll receive emails packed with the latest information and resources to live your best life and connect with others.
Every gift to the Arthritis Foundation will help people with arthritis across the U.S. live their best life.
Volunteer
Join us and become a Champion of Yes. There are many volunteer opportunities available.
Partner
Proud Partners of the Arthritis Foundation make an annual commitment to directly support the Foundation’s mission.
Donate
Ways to Give
Every gift to the Arthritis Foundation will help people with arthritis across the U.S. live their best life. Whether it is supporting cutting-edge research, 24/7 access to one-on-one support, resources and tools for daily living, and more, your gift will be life-changing.
Help millions of people live with less pain and fund groundbreaking research to discover a cure for this devastating disease. Please, make your urgently-needed donation to the Arthritis Foundation now!
Honor a loved one with a meaningful donation to the Arthritis Foundation. We'll send a handwritten card to the honoree or their family notifying them of your thoughtful gift.
The Arthritis Foundation is focused on finding a cure and championing the fight against arthritis with life-changing information, advocacy, science and community. We can only achieve these goals with your help. Strong, outspoken and engaged volunteers will help us conquer arthritis. By getting involved, you become a leader in our organization and help make a difference in the lives of millions. Join us and become a Champion of Yes.
As a partner, you will help the Arthritis Foundation provide life-changing resources, science, advocacy and community connections for people with arthritis, the nations leading cause of disability. Join us today and help lead the way as a Champion of Yes.
Our Visionary partners help us plan for a future that includes a cure for arthritis. These inspired and inventive champions have contributed $1,500,00 to $1,999,999.
Our Signature partners make their mark by helping us identify new and meaningful resources for people with arthritis. They contribute $250,000 to $499,999.
Our Supporting partners are active champions who provide encouragement and assistance to the arthritis community. They contribute $100,000 to $249,999.
